Three-dimensional skin models as tools for transdermal drug delivery: challenges and limitations

Bibliography

• Trommer H, Neubert RH. Overcoming the stratum corneum: the modulation of skin penetration. A review. Skin Pharmacol Physiol 2006;19:106-21
   PubMed Web of Science ®Google Scholar
• Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol 2008;8:1261-8
   Google Scholar
• Bouwstra JA, Honeywell-Nguyen PL, Gooris GS, Structure of the skin barrier and its modulation by vesicular formulations. Prog Lipid Res 2003;42:1-36
   PubMed Web of Science ®Google Scholar
• Choy YB, Prausnitz MR. The rule of five for non-oral routes of drug delivery: ophthalmic, inhalation and transdermal. Pharm Res 2010; doi 10.1007/s11095-010-0292-6
   Google Scholar
• Archer DF, Cullins V, Creasy GW, The impact of improved compliance with a weekly contraceptive transdermal system (Ortho Evra) on contraceptive efficacy. Contraception 2004;69:189-95
   PubMed Web of Science ®Google Scholar
• Miller MA, Pisani E. The cost of unsafe injections. Bull World Health Organ 1999;77:808-11
   PubMed Web of Science ®Google Scholar
• Thomas BJ, Finnin BC. The transdermal revolution. Drug Discov Today 2004;9:697-703
   PubMed Web of Science ®Google Scholar
• Prausnitz MR, Mitragotri S, Langer R. Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov 2004;3:115-24
   PubMed Web of Science ®Google Scholar
• Tanner T, Marks R. Delivering drugs by the transdermal route: review and comment. Skin Res Technol 2008;14:249-60
   PubMed Web of Science ®Google Scholar
• Foldvari M, Babiuk S, Badea I. DNA delivery for vaccination and therapeutics through the skin. Curr Drug Deliv 2006;3:17-28
   PubMedGoogle Scholar
• Geusens B, Sanders N, Prow T, Cutaneous short-interfering RNA therapy. Expert Opin Drug Deliv 2009;6:1333-49
   PubMed Web of Science ®Google Scholar
• Benson HA. Transdermal drug delivery: penetration enhancement techniques. Curr Drug Deliv 2005;2:23-33
   PubMedGoogle Scholar
• Priborsky J, Muhlbachova E. Evaluation of in-vitro percutaneous absorption across human skin and in animal models. J Pharm Pharmacol 1990;42:468-72
   PubMed Web of Science ®Google Scholar
• Godin B, Touitou E. Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models. Adv Drug Deliv Rev 2007;59:1152-61
   PubMed Web of Science ®Google Scholar
• El Maghraby GM, Barry BW, Williams AC. Liposomes and skin: from drug delivery to model membranes. Eur J Pharm Sci 2008;34:203-22
   PubMed Web of Science ®Google Scholar
• OECD. OECD guidelines for the in vitro testing of chemicals, No. 428: skin absorption: in vitro method. OECD, Paris, France; 2004. p. 8
   Google Scholar
• Wester RC, Christoffel J, Hartway T, Human cadaver skin viability for in vitro percutaneous absorption: storage and detrimental effects of heat-separation and freezing. Pharm Res 1998;15:82-4
   PubMed Web of Science ®Google Scholar
• MacNeil S. Progress and opportunities for tissue-engineered skin. Nature 2007;445:874-80
   PubMed Web of Science ®Google Scholar
• Netzlaff F, Lehr CM, Wertz PW, The human epidermis models EpiSkin, SkinEthic and EpiDerm: an evaluation of morphology and their suitability for testing phototoxicity, irritancy, corrosivity, and substance transport. Eur J Pharm Biopharm 2005;60:167-78
   PubMed Web of Science ®Google Scholar
• Kandarova H, Liebsch M, Spielmann H, Assessment of the human epidermis model SkinEthic RHE for in vitro skin corrosion testing of chemicals according to new OECD TG 431. Toxicol In Vitro 2006;20:547-59
   PubMed Web of Science ®Google Scholar
• Welss T, Basketter DA, Schroder KR. In vitro skin irritation: facts and future. State of the art review of mechanisms and models. Toxicol In Vitro 2004;18:231-43
   PubMed Web of Science ®Google Scholar
• Lelievre D, Justine P, Christiaens F, The EpiSkin phototoxicity assay (EPA): development of an in vitro tiered strategy using 17 reference chemicals to predict phototoxic potency. Toxicol In Vitro 2007;21:977-95
   PubMed Web of Science ®Google Scholar
• Menon GK. New insights into skin structure: scratching the surface. Adv Drug Deliv Rev 2002;54(Suppl 1):S3-17
   PubMedGoogle Scholar
• Elias PM, Tsai J, Menon GK, The potential of metabolic interventions to enhance transdermal drug delivery. J Investig Dermatol Symp Proc 2002;7:79-85
   PubMed Web of Science ®Google Scholar
• Holleran WM, Takagi Y, Menon GK, Processing of epidermal glucosylceramides is required for optimal mammalian cutaneous permeability barrier function. J Clin Invest 1993;91:1656-64
   PubMed Web of Science ®Google Scholar
• Jensen JM, Schutze S, Forl M, Roles for tumor necrosis factor receptor p55 and sphingomyelinase in repairing the cutaneous permeability barrier. J Clin Invest 1999;104:1761-70
   PubMed Web of Science ®Google Scholar
• Uchida Y, Hara M, Nishio H, Epidermal sphingomyelins are precursors for selected stratum corneum ceramides. J Lipid Res 2000;41:2071-82
   PubMed Web of Science ®Google Scholar
• Schuette CG, Pierstorff B, Huettler S, Sphingolipid activator proteins: proteins with complex functions in lipid degradation and skin biogenesis. Glycobiology 2001;11:81R-90R
   PubMed Web of Science ®Google Scholar
• Otberg N, Richter H, Schaefer H, Variations of hair follicle size and distribution in different body sites. J Invest Dermatol 2004;122:14-19
   PubMed Web of Science ®Google Scholar
• Lipinski CA, Lombardo F, Dominy BW, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 2001;46:3-26
   PubMed Web of Science ®Google Scholar
• Oji V, Eckl KM, Aufenvenne K, Loss of corneodesmosin leads to severe skin barrier defect, pruritus, and atopy: unraveling the peeling skin disease. Am J Hum Genet 2010;87:274-81
   PubMed Web of Science ®Google Scholar
• Bos JD, Meinardi MM. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol 2000;9:165-9
   PubMed Web of Science ®Google Scholar
• du Plessis J, Pugh WJ, Judefeind A, Physico-chemical determinants of dermal drug delivery: effects of the number and substitution pattern of polar groups. Eur J Pharm Sci 2002;16:107-12
   PubMed Web of Science ®Google Scholar
• Naik A, Kalia YN, Guy RH. Transdermal drug delivery: overcoming the skin's barrier function. Pharm Sci Technol Today 2000;3:318-26
   PubMedGoogle Scholar
• van de Sandt JJ, van Burgsteden JA, Cage S, In vitro predictions of skin absorption of caffeine, testosterone, and benzoic acid: a multi-centre comparison study. Regul Toxicol Pharmacol 2004;39:271-81
   PubMed Web of Science ®Google Scholar
• OECD. Guidance document for the conduct of skin absoption studies. Series on testing assessment No. 28. OECD, Paris, France; 2003
   Google Scholar
• OECD. OECD guideline for the testing of chemicals, No. 431. In vitro skin corrosion: human skin model test. OECD, Paris, France; 2004. p. 8
   Google Scholar
• OECD. OECD guideline for the testing of chemicals, No. 432. In vitro 3T3 NRU phototoxicity test. OECD, Paris, France; 2004. p. 15
   Google Scholar
• Prunieras M. Epidermal cell cultures as models for living epidermis. J Invest Dermatol 1979;73:135-7
   PubMed Web of Science ®Google Scholar
• El Ghalbzouri A, Lamme E, Ponec M. Crucial role of fibroblasts in regulating epidermal morphogenesis. Cell Tissue Res 2002;310:189-99
   PubMed Web of Science ®Google Scholar
• Bessou S, Surleve-Bazeille JE, Sorbier E, Ex vivo reconstruction of the epidermis with melanocytes and the influence of UVB. Pigment Cell Res 1995;8:241-9
   PubMedGoogle Scholar
• Eves P, Katerinaki E, Simpson C, Melanoma invasion in reconstructed human skin is influenced by skin cells–investigation of the role of proteolytic enzymes. Clin Exp Metastasis 2003;20:685-700
   PubMed Web of Science ®Google Scholar
• Parenteau NL, Nolte CM, Bilbo P, Epidermis generated in vitro: practical considerations and applications. J Cell Biochem 1991;45:245-51
   PubMed Web of Science ®Google Scholar
• Gibbs S, Vicanova J, Bouwstra J, Culture of reconstructed epidermis in a defined medium at 33 degrees C shows a delayed epidermal maturation, prolonged lifespan and improved stratum corneum. Arch Dermatol Res 1997;289:585-95
   PubMed Web of Science ®Google Scholar
• Ponec M, Weerheim A, Kempenaar J, The formation of competent barrier lipids in reconstructed human epidermis requires the presence of vitamin C. J Invest Dermatol 1997;109:348-55
   PubMed Web of Science ®Google Scholar
• Ponec M, Boelsma E, Gibbs S, Characterization of reconstructed skin models. Skin Pharmacol Appl Skin Physiol 2002;15(Suppl 1):4-17
   PubMedGoogle Scholar
• OECD. OECD guideline for the testing of chemicals, No. 427. Skin absorption: in vivo method. OECD, Paris; 2004
   Google Scholar
• Schreiber S, Mahmoud A, Vuia A, Reconstructed epidermis versus human and animal skin in skin absorption studies. Toxicol In Vitro 2005;19:813-22
   PubMed Web of Science ®Google Scholar
• Dick IP, Blain PG, Williams FM. The percutaneous absorption and skin distribution of lindane in man. II. In vitro studies. Hum Exp Toxicol 1997;16:652-7
   PubMed Web of Science ®Google Scholar
• Schafer-Korting M, Bock U, Gamer A, Reconstructed human epidermis for skin absorption testing: results of the German prevalidation study. Altern Lab Anim 2006;34:283-94
   PubMed Web of Science ®Google Scholar
• Schafer-Korting M, Bock U, Diembeck W, The use of reconstructed human epidermis for skin absorption testing: results of the validation study. Altern Lab Anim 2008;36:161-87
   PubMed Web of Science ®Google Scholar
• Magnusson BM, Anissimov YG, Cross SE, Molecular size as the main determinant of solute maximum flux across the skin. J Invest Dermatol 2004;122:993-9
   PubMed Web of Science ®Google Scholar
• Magnusson BM, Pugh WJ, Roberts MS. Simple rules defining the potential of compounds for transdermal delivery or toxicity. Pharm Res 2004;21:1047-54
   PubMed Web of Science ®Google Scholar
• Schmook FP, Meingassner JG, Billich A. Comparison of human skin or epidermis models with human and animal skin in in-vitro percutaneous absorption. Int J Pharm 2001;215:51-6
   PubMed Web of Science ®Google Scholar
• Sweeney TM, Downing DT. The role of lipids in the epidermal barrier to water diffusion. J Invest Dermatol 1970;55:135-40
   PubMed Web of Science ®Google Scholar
• Bronaugh RL, Franz TJ. Vehicle effects on percutaneous absorption: in vivo and in vitro comparisons with human skin. Br J Dermatol 1986;115:1-11
   PubMed Web of Science ®Google Scholar
• Elias PM, Menon GK. Structural and lipid biochemical correlates of the epidermal permeability barrier. Adv Lipid Res 1991;24:1-26
   PubMedGoogle Scholar
• McIntosh TJ, Stewart ME, Downing DT. X-ray diffraction analysis of isolated skin lipids: reconstitution of intercellular lipid domains. Biochemistry 1996;35:3649-53
   PubMed Web of Science ®Google Scholar
• Elias PM. Epidermal lipids, membranes, and keratinization. Int J Dermatol 1981;20:1-19
   PubMed Web of Science ®Google Scholar
• Williams ML, Elias PM. The extracellular matrix of stratum corneum: role of lipids in normal and pathological function. Crit Rev Ther Drug Carrier Syst 1987;3:95-122
   PubMed Web of Science ®Google Scholar
• Lampe MA, Williams ML, Elias PM. Human epidermal lipids: characterization and modulations during differentiation. J Lipid Res 1983;24:131-40
   PubMed Web of Science ®Google Scholar
• Asbill C, Kim N, El-Kattan A, Evaluation of a human bio-engineered skin equivalent for drug permeation studies. Pharm Res 2000;17:1092-7
   PubMed Web of Science ®Google Scholar
• Ponec M, Weerheim A, Kempenaar J, Lipid composition of cultured human keratinocytes in relation to their differentiation. J Lipid Res 1988;29:949-61
   PubMed Web of Science ®Google Scholar
• Ackermann K, Borgia SL, Korting HC, The Phenion full-thickness skin model for percutaneous absorption testing. Skin Pharmacol Physiol 2009;23:105-12
   PubMed Web of Science ®Google Scholar
• Schafer-Korting M, Mahmoud A, Lombardi Borgia S, Reconstructed epidermis and full-thickness skin for absorption testing: influence of the vehicles used on steroid permeation. Altern Lab Anim 2008;36:441-52
   PubMed Web of Science ®Google Scholar
• Megrab NA, Williams AC, Barry BW. Oestradiol permeation across human skin, silastic and snake skin membranes: the effects of ethanol/water co-solvent systems. Int J Pharm 1995;116:101-12
   Web of Science ®Google Scholar
• Megrab NA, Williams AC, Barry BW. Oestradiol permeation through human skin and silastic membrane: effects of propylene glycol and supersaturation. Int J Pharm 1995;36:277-94
   Google Scholar
• Iervolino M, Cappello B, Raghavan SL, Penetration enhancement of ibuprofen from supersaturated solutions through human skin. Int J Pharm 2001;212:131-41
   PubMed Web of Science ®Google Scholar
• Dias M, Farinha A, Faustino E, Topical delivery of caffeine from some commercial formulations. Int J Pharm 1999;182:41-7
   PubMed Web of Science ®Google Scholar
• Leveque N, Raghavan SL, Lane ME, Use of a molecular form technique for the penetration of supersaturated solutions of salicylic acid across silicone membranes and human skin in vitro. Int J Pharm 2006;318:49-54
   PubMedGoogle Scholar
• Geinoz S, Rey S, Boss G, Quantitative structure-permeation relationships for solute transport across silicone membranes. Pharm Res 2002;19:1622-9
   PubMed Web of Science ®Google Scholar
• Sugibayashi K, Todo H, Oshizaka T, Mathematical model to predict skin concentration of drugs: toward utilization of silicone membrane to predict skin concentration of drugs as an animal testing alternative. Pharm Res 2010;27:134-42
   PubMed Web of Science ®Google Scholar
• Doucet O, Ferrero L, Garcia N, O/W emulsion and W/O/W multiple emulsion: physical characterization and skin pharmacokinetic comparison in the delivery process of caffeine. Int J Cosmet Sci 1998;20:283-95
   PubMedGoogle Scholar
• Ernesti AM, Swiderek M, Gay R. Absorption and metabolism of topically applied testosterone in an organotypic skin culture. Skin Pharmacol 1992;5:146-53
   PubMedGoogle Scholar
• Gay R, Swiderek M, Nelson D, The living skin equivalent as a model in vitro for ranking the toxic potential of dermal irritants. Toxicol In Vitro 1992;6:303-15
   PubMed Web of Science ®Google Scholar
• Zghoul N, Fuchs R, Lehr CM, Reconstructed skin equivalents for assessing percutaneous drug absorption from pharmaceutical formulations. Altex 2001;18:103-6
   PubMed Web of Science ®Google Scholar
• Dreher F, Fouchard F, Patouillet C, Comparison of cutaneous bioavailability of cosmetic preparations containing caffeine or alpha-tocopherol applied on human skin models or human skin ex vivo at finite doses. Skin Pharmacol Appl Skin Physiol 2002;15(Suppl 1):40-58
   PubMedGoogle Scholar
• Bando H, Mohri S, Yamashita F, Effects of skin metabolism on percutaneous penetration of lipophilic drugs. J Pharm Sci 1997;86:759-61
   PubMed Web of Science ®Google Scholar
• Gysler A, Kleuser B, Sippl W, Skin penetration and metabolism of topical glucocorticoids in reconstructed epidermis and in excised human skin. Pharm Res 1999;16:1386-91
   PubMed Web of Science ®Google Scholar
• Lombardi Borgia S, Schlupp P, Mehnert W, In vitro skin absorption and drug release – a comparison of six commercial prednicarbate preparations for topical use. Eur J Pharm Biopharm 2008;68:380-9
   PubMed Web of Science ®Google Scholar
• Mahmoud A, Haberland A, Durrfeld M, Cutaneous estradiol permeation, penetration and metabolism in pig and man. Skin Pharmacol Physiol 2005;18:27-35
   PubMed Web of Science ®Google Scholar
• Slivka SR. Testosterone metabolism in an in vitro skin model. Cell Biol Toxicol 1992;8:267-76
   PubMed Web of Science ®Google Scholar
• Haberland A, Santos Maia C, Jores K, Albumin effects on drug absorption and metabolism in reconstructed epidermis and excised pig skin. Altex 2003;20:3-9
   PubMed Web of Science ®Google Scholar
• Oesch F, Fabian E, Oesch-Bartlomowicz B, Drug-metabolizing enzymes in the skin of man, rat, and pig. Drug Metab Rev 2007;39:659-98
   PubMed Web of Science ®Google Scholar
• Stinchcomb AL. Xenobiotic bioconversion in human epidermis models. Pharm Res 2003;20:1113-18
   PubMed Web of Science ®Google Scholar
• Lotte C, Patouillet C, Zanini M, Permeation and skin absorption: reproducibility of various industrial reconstructed human skin models. Skin Pharmacol Appl Skin Physiol 2002;15(Suppl 1):18-30
   PubMedGoogle Scholar
• Ponec M. Skin constructs for replacement of skin tissues for in vitro testing. Adv Drug Deliv Rev 2002;54(Suppl 1):S19-30
   PubMedGoogle Scholar
• Ponec M, Gibbs S, Pilgram G, Barrier function in reconstructed epidermis and its resemblance to native human skin. Skin Pharmacol Appl Skin Physiol 2001;14(Suppl 1):63-71
   PubMedGoogle Scholar
• Bouwstra JA, Gooris GS, Weerheim A, Characterization of stratum corneum structure in reconstructed epidermis by X-ray diffraction. J Lipid Res 1995;36:496-504
   PubMed Web of Science ®Google Scholar
• Ponec M, Kempenaar J, Weerheim A. Lack of desquamation – the Achilles heel of the reconstructed epidermis. Int J Cosmet Sci 2002;24:263-72
   PubMedGoogle Scholar
• Vicanova J, Mommaas AM, Mulder AA, Impaired desquamation in the in vitro reconstructed human epidermis. Cell Tissue Res 1996;286:115-22
   PubMed Web of Science ®Google Scholar
• Boukamp P, Petrussevska RT, Breitkreutz D, Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 1988;106:761-71
   PubMed Web of Science ®Google Scholar
• Stark HJ, Szabowski A, Fusenig NE, Organotypic cocultures as skin equivalents: a complex and sophisticated in vitro system. Biol Proc Online 2004;6:55-60
   PubMedGoogle Scholar
• Cross SE, Magnusson BM, Winckle G, Determination of the effect of lipophilicity on the in vitro permeability and tissue reservoir characteristics of topically applied solutes in human skin layers. J Invest Dermatol 2003;120:759-64
   PubMed Web of Science ®Google Scholar
• Sahota PS, Burn JL, Heaton M, Development of a reconstructed human skin model for angiogenesis. Wound Repair Regen 2003;11:275-84
   PubMed Web of Science ®Google Scholar